Literature DB >> 18573420

Liver and cardiac function in the long term after Fontan operation.

Sonia Camposilvan1, Ornella Milanesi, Giovanni Stellin, Andrea Pettenazzo, Lucia Zancan, Lorenzo D'Antiga.   

Abstract

BACKGROUND: Patients who underwent Fontan operation have some degree of liver disease. We aimed to assess the long-term liver and cardiac function after Fontan operation.
METHODS: Patients enrolled underwent physical examination, biochemical tests (aspartate aminotransferase, alanine aminotransferase, gamma glutamyl transpeptidase, bilirubin, international normalized ratio, coagulation factor V, protein profile, fecal alpha-1-antitrypsin), echocardiogram, and liver ultrasonography. A liver disease score was adopted to compare the degree of liver involvement with hemodynamic features.
RESULTS: The study enrolled 34 patients, median age 14.7 years (range, 4.1 to 26.7), 26 with a residual left ventricle, 8 with a residual right ventricle, affected by tricuspid atresia (17), pulmonary atresia (4), hypoplastic left heart syndrome (5), double-outlet right ventricle (2), single left ventricle (2), and miscellaneous (4), with median follow-up of 11.5 years (range, 1.7 to 23.3). We found hepatomegaly in 18 of 34 (53%), splenomegaly in 3 of 33 (9%), abnormal transaminases in 10 of 33 (30%), elevated gamma GT in 19 of 31 (61%), elevated bilirubin in 10 of 31 (32%), coagulopathy in 17 of 29 (58%), and protein-losing enteropathy in 4 of 21 (19%). Median heart rate z-score was -1.72. Hepatic dysfunction was strictly correlated to low cardiac index (r(2) = 0.34, p = 0.008) and to a lesser extent to reduced heart rate (r(2) = 0.18, p = 0.07).
CONCLUSIONS: In children who underwent Fontan operation, hepatic dysfunction is correlated with low cardiac index and reduced heart rate. Maintaining or reestablishing a normal cardiac index might prevent or reduce liver disease in the long-term.

Entities:  

Mesh:

Year:  2008        PMID: 18573420     DOI: 10.1016/j.athoracsur.2008.03.077

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  25 in total

1.  Serial evaluation of hepatic function profile after Fontan operation.

Authors:  R Kaulitz; P Haber; E Sturm; J Schäfer; M Hofbeck
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

2.  Hepatic pathology after Fontan palliation: spectrum of imaging findings.

Authors:  Daniel B Wallihan; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2012-10-06

3.  Mechanisms of systemic adaptation to univentricular Fontan conversion.

Authors:  Cynthia D Myers; Kimberly Ballman; Lindsay E Riegle; Kelly D Mattix; Kenneth Litwak; Mark D Rodefeld
Journal:  J Thorac Cardiovasc Surg       Date:  2010-05-18       Impact factor: 5.209

Review 4.  MR assessment of abdominal circulation in Fontan physiology.

Authors:  Shi-Joon Yoo; Milan Prsa; Daryl Schantz; Lars Grosse-Wortmann; Mike Seed; Tae Kyoung Kim; Rachel Wald; Rajiv Chaturvedi
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-22       Impact factor: 2.357

5.  Two-ventricle repair for complex congenital heart defects palliated towards single-ventricle repair.

Authors:  Brijesh P Kottayil; Gopalraj S Sunil; Mahesh Kappanayil; Sweta Harish Mohanty; Edwin Francis; Balu Vaidyanathan; Rakhi Balachandran; Suresh G Nair; Raman Krishna Kumar
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-05

Review 6.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

7.  Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.

Authors:  Joseph T Poterucha; Jonathan N Johnson; M Yasir Qureshi; Patrick W O'Leary; Patrick S Kamath; Ryan J Lennon; Crystal R Bonnichsen; Phillip M Young; Sudhakar K Venkatesh; Richard L Ehman; Sounak Gupta; Thomas C Smyrk; Joseph A Dearani; Carole A Warnes; Frank Cetta
Journal:  Mayo Clin Proc       Date:  2015-06-06       Impact factor: 7.616

8.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

9.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07

10.  Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function.

Authors:  Kathleen E Simpson; Amir Esmaeeli; Geetika Khanna; Francis White; Yumirle Turnmelle; Pirooz Eghtesady; Umar Boston; Charles E Canter
Journal:  J Heart Lung Transplant       Date:  2013-10-25       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.